Hawaii bills · 2026 Regular Session
Hawaii HB 1767
RELATING TO OPIOID ANTAGONISTS.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- KAPELA (Democratic)
- AMATO (Democratic)
- EVSLIN (Democratic)
- GEDEON (Republican)
- ILAGAN (Democratic)
- IWAMOTO (Democratic)
- KEOHOKAPU-LEE LOY (Democratic)
- KUSCH (Democratic)
- LOWEN (Democratic)
- MARTEN (Democratic)
- MATSUMOTO (Republican)
- OLDS (Democratic)
- PERRUSO (Democratic)
- POEPOE (Democratic)
- REYES ODA (Republican)
- SOUZA (Republican)
- TAKAYAMA (Democratic)
- TAKENOUCHI (Democratic)
- TAM (Democratic)
- TARNAS (Democratic)
- TODD (Democratic)
Summary
Official abstract published by the Hawaii legislature· description
Beginning 1/1/2027, requires health insurers, mutual benefit societies, and health maintenance organizations that issue policies, contracts, plans, or agreements that provide prescription drug coverage to provide coverage for at least one generic opioid antagonist and device.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 21, 2026 · House
Pending introduction. - Jan 22, 2026 · House
Introduced and Pass First Reading. - Jan 26, 2026 · House
Referred to HLT, CPC, referral sheet 1